Anthropic has opened applications for a new round of its AI for Science programme focused on rare genetic diseases, offering ...

The government has expressed its determination to prevent regional decline and open the nation’s future through three ...

When Chinese drug developers need to see exactly how an experimental medicine binds to its target protein, or materials ...

By wielding an unusual combination of long-term strategic patience and real-time institutional agility, Shanghai is forging a distinctively Chinese model for original innovation ...

The next phase of growth is shifting from science to scale — infrastructure is required to produce alternative proteins with precision and consistency required of these systems.

Discover why transparency is essential in peptide research, strengthening scientific integrity, regulatory compliance, data ...

Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in ...

Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second ...

The same billionaires accelerating A.I. are pouring money into safety research, public-interest tools, health care and ...

Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential ...

GUO YALI/CHINA DAILY China is actively exploring innovative approaches to organizing biomedical research, betting that ...

Bio Protocol is building what amounts to an AI workforce for decentralized science. The platform, which operates as a financial ecosystem for tokenized biotech research, has rolled out BioAgents and a ...